PK MED
PK MED creates custom-designed, intravenous, and biodegradable micro-implants suggesting a focus on advanced medical technology aimed at precise and potentially minimally invasive treatments.
PK MED
Social Links:
Industry:
Biotechnology
Founded:
2018-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.pk-med.com
Total Employee:
1+
Status:
Active
Total Funding:
1.5 M EUR
Technology used in webpage:
Google Google Cloud Wix Pexels
Similar Organizations
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Allevi
Allevi offers bioprinters that enable users to experiment with any biomaterial, work with any cell line, and print in any geometry.
Draupnir Bio
Draupnir Bio is developing a new type of cholesterol-lowering medicine which prevents blood clots in the heart.
ExpressCells
ExpressCells creates custom cell lines for biological research and drug discovery.
Interius BioTherapeutics
Interius BioTherapeutics is a biopharmaceutical company developing a paradigm-shifting platform for in vivo cell-specific gene delivery.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Nodexus
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Scailyte
True precision medicine through single-cell science
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Investors List
Bpifrance
Bpifrance investment in Grant - PK MED
Official Site Inspections
http://www.pk-med.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "PK MED"
PK MED | Treatment in gout flares
PK MED has developed a portfolio of early projects in indications with high unmet medical needs, starting with Gout flare (PKM-01), Osteoarthritis (PKM-011) and Hemoglobinopathies (PKM …See details»
About us | PK MED
PK MED is a French innovative biotech company, privately owned and established in 2019 with the support of Truffle Capital, a prominent European Venture Capital firm specializing in Life …See details»
PK MED - Crunchbase Company Profile & Funding
Organization. PK MED . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. PK MED focuses on the unique creation of …See details»
PK MED Company Profile | Management and Employees List
PK MED Profile and History PK MED specializes in developing innovative treatments for medical conditions with significant unmet needs, focusing on gout flares, osteoarthritis, and …See details»
PK MED - VentureRadar
The company focuses on advanced drug delivery systems for rheumatology and enhancing cell-homing techniques to improve bone marrow transplantation outcomes. PK MED's portfolio …See details»
PK MED - LinkedIn
PK MED is a pioneering French biotech company, privately owned and founded in 2019 in Lyon, France, with the backing of Truffle Capital, a leading European venture capital firm specializing in ...See details»
PK MED 2025 Company Profile: Valuation, Funding
PK MED General Information Description. Developer of injectable small molecules and biodegradable micro-implants intended to improve bone marrow transplantation outcomes. The Company offers different approaches to …See details»
PK MED - Funding, Financials, Valuation & Investors - Crunchbase
Jul 24, 2024 PK MED focuses on the unique creation of custom-designed, intravenous, and biodegradable micro-implants. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
PK Med – Truffle Capital
Feb 26, 2024 PK MED, founded by Truffle Capital in 2019, is a Biotech developing novel drug delivery mechanisms for inflammatory joint diseases (gout flares and osteoarthritis). LATEST …See details»
PK MED SAS - Drug pipelines, Patents, Clinical trials - Synapse
100 Clinical Results associated with PK MED SAS. Login to view more data. 0 Patents (Medical) associated with PK MED SAS. Login to view more data. 100 Deals associated with PK MED …See details»
PK MED Company Profile | PARIS, ILE DE FRANCE, France
PK MED Company Profile | PARIS, ILE DE FRANCE, France | Competitors, Financials & Contacts - Dun & BradstreetSee details»
PK MED - Tech Company Profile - Gaebler.com Venture Capital …
Jul 24, 2024 PK MED. Headquartered in Paris, PK MED has funding from Bpifrance. Company Overview. Company Name. PK MED. Company Status. Private & Independent. Industry. Life …See details»
PK MED Company Profile | LYON, AUVERGNE RHONE ALPES, …
Find company research, competitor information, contact details & financial data for PK MED of LYON, AUVERGNE RHONE ALPES. Get the latest business insights from Dun & Bradstreet.See details»
PK MED - VentureRadar
PK MED specializes in developing tailor-designed drug implants for localized treatment of gout flares. By focusing on precision and targeted delivery, PK MED aims to provide effective relief …See details»
PK MED - Societe.com
PK MED, société par actions simplifiée, au capital social de 730000,00 EURO, dont le siège social est situé au 12 RUE JEAN ANTOINE DE BAIF, 75013 PARIS, immatriculée au Registre …See details»
PK MED Announces FDA Clearance to Initiate Its Clinical Program …
PARIS, February 26, 2024--PK MED, a biotechnology company developing injectable smart implants for drug release in rheumatology and cell homing for bone marrow transplantation, …See details»
PK MED announces FDA clearance to initiate its clinical program
PKM-01 is a local intra-articular injection treatment for gout flares, developed by PK MED, aiming to provide a fast an effective pain relief and powerful and safe anti-inflammatory effect. Thanks …See details»
PK Med Ltd. Company Profile - Dun & Bradstreet
PK Med Ltd. Company Profile | Gwangju, Gwangju, Republic Of Korea | Competitors, Financials & Contacts - Dun & BradstreetSee details»
PK MED Announces FDA Clearance to Initiate Its Clinical Program …
Feb 26, 2024 PK MED is now entering the fund-raising phase to finance PKM-01 phase 2 clinical trials. With a robust patent protection and a clear path to deliver phase 2 results, PKM-01 …See details»
#PK MED-新闻标签聚合 -共1条- 第1页-ByDrug-一站式医药资源共 …
Feb 26, 2024 pk med所研的是一种治疗痛风的局部关节内注射治疗方法，研发代码pkm-01。其在pre-1ind的b类会议上，展现出的低毒性风险，获得fda的青睐，将直接从2期开始临床研究，大 …See details»